The webinar 'Manufacturing of Highly Potent Sterile Parenterals – Mobile Isolator Based Technology' was hosted by Piramal Pharma Solutions in association with Manufacturing Chemist, on 16 September 2020 and is available to watch for free on demand
With increased demand in the pharmaceutical space amid a global health crisis, the need for contract aseptic fill/finish services continues to rise. Aseptic manufacturing of highly potent sterile parenteral drug products continue to be a challenge.
This webinar gives an overview of manufacturing of highly potent sterile parenteral drug products using mobile isolator based technology. It also discusses clean room classifications, the controls required for aseptic processing and the advantages of using isolators.
Dr. Sundar (Sunny) Neelakantan
Director of Development
Piramal Pharma Solutions
Dr. Sunny Neelakantan is currently the Director of Pharmaceutical Development responsible for both Formulation and Analytical development at Piramal Pharma Solutions, Lexington, Kentucky USA. He graduated from Indian Institute of Technology (I.I.T) Mumbai with a Ph.D. in Medicinal Chemistry and has postdoctoral training in Pharmaceutical Sciences in United States of America. He has 18+ years of pharmaceutical industry experience developing several complex sterile parenteral drug products / dosage forms including lyophilization cycle development and optimisation. Dr. Sunny Neelakantan has also published 25+ academic publications in high impact journals and has 4 patents to his credit and 30+ conference poster presentations.